	Unlocking Parkinson's disease: harnessing the untapped potential of fatty acid metabolism in disease pathogenesis. Front Immunol Hu R, Song Y, Liu T, He X, Qiu Y, Zhong F, Huang X, Huang J, Jiao Z. PMID: 42813030 [PubMed - indexed for MEDLINE]
	Home-based virtual reality telerehabilitation for people with Parkinson's disease: a scoping review of delivery, supervision and implementation. BMJ Open Naqvi I, Vardhan V, Khatib N. PMID: 42810801 [PubMed - indexed for MEDLINE]
	Parkinson's disease: Clinical update and new diagnostic and therapeutic approaches. Med Clin (Barc) Rábano-Suárez P, Ramírez Sánchez-Ajofrín J, Santos-García D. PMID: 42810206 [PubMed - as supplied by publisher]
	Exploring the link between subjective sleep quality and nocturnal cardiac autonomic function in Parkinson's disease: A cross-sectional study using 24-hour ambulatory electrocardiography. J Clin Neurosci Liu Y, Wang P, Wang R, Fang J, Liu Y, Su Y, Wang Y, Liu A, Fang B. PMID: 42810123 [PubMed - as supplied by publisher]
	The effects of dual-task training with different task priorities on physical performance and cognitive status in patients with Parkinson's disease: a single-blind, randomized controlled trial. Neurol Sci Özcan Gül, Söke F, Gül, Tokçaer Bora HA, Tunca Ö. PMID: 42809128 [PubMed - indexed for MEDLINE]
	A neuroimmune-enriched multibiofluid proteomic index associated with cognitive-motor progression in early Parkinson's disease: a longitudinal PPMI cohort study. Front Immunol Wang H, Wu G, Zhang D, Feng W, Zhao X, Zhang W, Du G. PMID: 42807025 [PubMed - indexed for MEDLINE]
	Clinician perspectives on OFF periods in Parkinson's disease: the Spanish PARK-OFF survey-based study. Front Neurol Ruiz-Martínez J, Rezola EM, Aragón AV, Vilella LP, Marcos MSC, Caballero DC, PARK-OFF Study group. PMID: 42806998 [PubMed - indexed for MEDLINE]
	Î±-Synuclein Seeding Discriminates Between LRRK2 G2019S Variant Carriers with and Without Parkinson's Disease. Mov Disord Lüth T, Gabbert C, Kleinz T, Much C, Laabs BH, Sendel S, König IR, Caliebe A, Farrer M, Fiske B, Blauwendraat C, Klein C, Trinh J, Global Parkinson's Genetics Program (GP2). PMID: 42806694 [PubMed - as supplied by publisher]
	Improving Video-Based Prediction of Cerebellar Ataxia Severity Using a Pretrained Deep Learning Model. Brain Behav Eguchi K, Yaguchi H, Uwatoko H, Iida Y, Yamada M, Hamada S, Sato K, Honma S, Takei A, Kawashima A, Moriwaka F, Fukazawa T, Togo R, Ogawa T, Haseyama M, Hirata K, Kudo K, Tanaka S, Yabe I. PMID: 42806624 [PubMed - indexed for MEDLINE]
	Continuous infusion therapy after deep brain stimulation in Parkinson's disease: indications, outcomes, and patient selection. J Neural Transm (Vienna) Hero M, Papi, Grozdani, Vuleti. PMID: 42806146 [PubMed - as supplied by publisher]
	Oral Environment and Aspiration Pneumonia Risk in Parkinson's Disease: A Narrative Review and Conceptual Framework. J Oral Rehabil Furuya H, Longnecker D, Almazan E, Hinojosa O, Rochester T, Carnaby G. PMID: 42805786 [PubMed - as supplied by publisher]
	Advances in the management of depression in Parkinson's disease: A narrative review on vortioxetine, hyperbaric oxygen, and physical activity. Biomed Pharmacother Mesquita I, Araújo B, Soares-Guedes C, Teixeira C, Caridade-Silva R, Summavielle T, Pinto L, Domingos J, Godinho C, Teixeira FG. PMID: 42805007 [PubMed - as supplied by publisher]
	Explicit Mechanistic Causal Analyses or Interventional Trials Are Required for Objective, Clinical, Voice-Based Parkinson Disease Characterization. J Med Internet Res Little M. PMID: 42804162 [PubMed - indexed for MEDLINE]
	Interlocking pentagons task and visuospatial deficit in parkinsonian syndrome: a quantitative approach. J Neurol Donzuso G, Cilio F, Ferrante E, D'Agate C, Fazzina G, Cicero CE, Mostile G, Nicoletti A, Zappia M. PMID: 42804007 [PubMed - indexed for MEDLINE]
	Genetic architecture and molecular pathogenesis of Parkinson's disease: emerging mechanisms and therapeutic targets. Metab Brain Dis Yildirim S. PMID: 42803978 [PubMed - indexed for MEDLINE]
	Selective umami taste impairment in anosmic Parkinson's disease: associations with non-motor symptoms. Ideggyogy Sz Yavuz Z, Önder H, Eldek FA, Çomoglu SS. PMID: 42803097 [PubMed - indexed for MEDLINE]
	The patient-centric development of an inclusive multi-arm multi-stage trial for Parkinson's disease. Brain Commun Zeissler ML, Burnell M, Barber TR, Ben-Shlomo Y, Clarke CS, Collins S, Counsell C, Duffen J, Edwards MJ, Ellis-Doyle R, Gonzalez-Robles C, Hockey K, Jewell A, Lawton M, Mills G, Petty R, Salathiel D, Whipps S, Whone A, Gandhi S, Carroll CB, Foltynie T, Carpenter JR, Barker RA, EJS ACT-PD Consortium, EJS ACT-PD Consortium. PMID: 42802821 [PubMed]
	Mendelian randomization analysis reveals causal links between specific immune cell phenotypes and Parkinson's disease. Clinics (Sao Paulo) Su Y, Cai S, Xu Y, Xu Q, Wang Q, Chen X. PMID: 42801837 [PubMed - as supplied by publisher]
	Comparative study of Parkinson's disease phenotypes in homozygous and heterozygous LRRK2-G2019S mutation carriers. Acta Neurol Belg Abida Y, Sghaier I, Gharbi A, Souissi A, Elloumi M, Atrous A, Gargouri A, Kacem I, Gouider R. PMID: 42801451 [PubMed - as supplied by publisher]
	Ambroxol in Gaucher disease and GBA1-related Parkinson disease: an updated systematic review. Acta Neurol Belg Lipi, Jezela-Stanek A, Tylki-Szyma. PMID: 42801449 [PubMed - as supplied by publisher]

Articles 1 - 20 / 59019

Page 1 of 2951



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy